Strong future prospect as a pharma company, too many re-orgs, very few opportunities outside NY if not in R&D - Mitarbeiter (anonym) bei Pfizer: Mitarbeiterbewertung

3,0
3. Nov. 2017
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Robust pipeline. Solid processes in place Future outlook is strong Good colleagues

Kontras

Risk averse Too many processes Too frequent re-orgs disruptive to doing what is important i.e. drug development

Mehr Bewertungen zu Pfizer entdecken

5,0
28. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Amazing office, supportive team, program is meant to support interns

Kontras

No return offers were given to my department

2,0
3. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

A good amount of remote monitoring, which depending on how you view can be a positive.

Kontras

Changing systems and inconsistent standards are applied to people. There are many differing models that often muddy how you are supposed to do your job, especially when other staff members don't quite understand. How do you interface with the changing models? There tends to be a lot of blame and foisting of responsibilities. Sometimes you can become overburdened with a lot of work, where people do not respect your time and think that their tasks should take priority. It is possible to be contacted late at night with work to do and then be criticized the next day for not being able to keep up.

1
Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle